Riskpilot← Back to searchSign inGet full accessMassanalys Spectrometry Nordic AB
ABActiveOrg 5567302004Biskopsvägen 9Business and other management consultancy activities · NACE 7020Est. 20071 employees
Revenue 2025
SEK 2,6M
-16% vs 2024
EBITDA margin
12.9%
-72% vs 2024
Equity ratio
99.1%
Financial strength
Net profit 2025
SEK 266K
-72% vs 2024
| Revenue | SEK 2,6M | -16% |
| EBITDA | SEK 335K | -72% |
| Net profit | SEK 266K | -72% |
| Total assets | SEK 6,4M | +1% |
| Equity | SEK 6,4M | +1% |
| Employees | 1 | — |
Legal name
Massanalys Spectrometry Nordic AB
Org number
5567302004
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
22 maj 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva försäljning av analysutrustning för lab och kemiska processer. I första hand utrustning baserat på tekniken masspektrometri.
Address
Biskopsvägen 9
Email
bengt.sandgarde@msnordic.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 662 | 3 337 | 1 584 | 3 088 | 2 589 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 246 | 1 897 | 371 | 1 214 | 335 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 246 | 1 897 | 371 | 1 214 | 335 |
| Net financials | — | — | 14 | 13 | 9 |
| Profit before tax | 246 | 1 898 | 385 | 1 227 | 344 |
| Tax | −56 | −397 | −85 | −263 | −78 |
| Net profit | 190 | 1 501 | 300 | 964 | 266 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 204 | 5 544 | 5 620 | 6 382 | 6 441 |
| Equity | 4 147 | 5 461 | 5 565 | 6 325 | 6 381 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 57 | 84 | 55 | 58 | 60 |
| Total debt | 57 | 84 | 55 | 58 | 60 |
EBITDA margin
12.9%
This company
15.8%
Market median
-18% vs market
20212025
Equity ratio
99.1%
This company
38.2%
Market median
+159% vs market
20212025
Return on equity
4.2%
This company
18.4%
Market median
-77% vs market
20212025
Net profit margin
10.3%
This company
8.1%
Market median
+27% vs market
20212025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
BW Chief Executive Officer | Chief Executive Officer | 2022 |
PG Chief Auditor | Chief Auditor | 2022 |
LM Auditor Substitute | Auditor Substitute | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Massanalys Spectrometry Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt William Sandgärde | Chief Executive Officer | 0 companies |
| Per Gustaf Hammar | Chief Auditor | 0 companies |
| Lars Mattias Eklöf | Auditor Substitute | 0 companies |
| Mary Ann-Charlotte Sandgärde | Deputy Board Member | 0 companies |